 Azathioprine treatment children inflammatory bowel disease period patients azathioprine mg/kg/day adjunct customary regimen Nine patients ulcerative colitis patients Crohn disease patients ages years median duration disease start azathioprine therapy years median follow-up years Sixteen patients therapy patients disease group complete responses patients ulcerative colitis Crohn disease partial responses patients ulcerative colitis patients Crohn disease median time patients months patients ulcerative colitis months Crohn disease Reduction corticosteroid dose possible patients therapy minimal side effects attributable drug azathioprine effective adjunctive agent treatment inflammatory bowel disease childhood questions long-term safety use children refractory disease severe unacceptable side effects corticosteroids